- Home
- JMM vs CCEL Comparison
JMM vs CCEL Comparison
Compare JMM & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- CCEL
- Stock Information
- Founded
- JMM 1988
- CCEL 1989
- Country
- JMM United States
- CCEL United States
- Employees
- JMM N/A
- CCEL N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- CCEL Managed Health Care
- Sector
- JMM Finance
- CCEL Health Care
- Exchange
- JMM Nasdaq
- CCEL Nasdaq
- Market Cap
- JMM 58.2M
- CCEL 51.9M
- IPO Year
- JMM N/A
- CCEL 1997
- Fundamental
- Price
- JMM $6.04
- CCEL $5.82
- Analyst Decision
- JMM
- CCEL Strong Buy
- Analyst Count
- JMM 0
- CCEL 1
- Target Price
- JMM N/A
- CCEL $8.50
- AVG Volume (30 Days)
- JMM 16.1K
- CCEL 11.7K
- Earning Date
- JMM 01-01-0001
- CCEL 04-15-2025
- Dividend Yield
- JMM 5.44%
- CCEL 4.27%
- EPS Growth
- JMM N/A
- CCEL N/A
- EPS
- JMM N/A
- CCEL 0.01
- Revenue
- JMM N/A
- CCEL $32,102,750.00
- Revenue This Year
- JMM N/A
- CCEL $2.21
- Revenue Next Year
- JMM N/A
- CCEL $0.98
- P/E Ratio
- JMM N/A
- CCEL $365.46
- Revenue Growth
- JMM N/A
- CCEL 2.33
- 52 Week Low
- JMM $5.29
- CCEL $4.96
- 52 Week High
- JMM $6.10
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- JMM 48.95
- CCEL 44.23
- Support Level
- JMM $5.83
- CCEL $5.37
- Resistance Level
- JMM $5.96
- CCEL $5.70
- Average True Range (ATR)
- JMM 0.14
- CCEL 0.46
- MACD
- JMM -0.01
- CCEL 0.03
- Stochastic Oscillator
- JMM 58.06
- CCEL 50.89
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.